Pandemic's hidden toll: MS relapse care under scrutiny
NCT ID NCT04858763
First seen Mar 20, 2026 · Last updated May 07, 2026 · Updated 8 times
Summary
This study looked at how the COVID-19 pandemic changed the way multiple sclerosis (MS) relapses were reported and managed. Researchers compared 51 patients who had a relapse during the first wave of the pandemic (April-June 2020) to those who had a relapse during the same months in 2019. The goal was to see if the pandemic affected treatment decisions, such as use of steroids or disease-modifying drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nottingham University Hospitals NHS Trust
Nottingham, NG72UH, United Kingdom
Conditions
Explore the condition pages connected to this study.